Glenmark Pharmaceuticals

Founded more than 40 years ago, Glenmark Pharmaceuticals is a global pharmaceutical company with a remarkable track record of achievement and improving patients’ lives with access to affordable medicines. Established in 2003 as a North American subsidiary of Glenmark Pharmaceuticals, we launched our first generic product in January 2005 and quickly emerged as one of the leading generic organizations in the United States.

Glenmark has the stability, resources and talent to work on solving serious medical problems, all while doing the right thing for patients, people and communities.

Today we have a diverse business. As a global leader in generics, we are leveraging our industry expertise and success to fuel extensive research to expand development in specialty branded products innovative products that are intended to have a major impact on how people live.

Our scientific and commercial goals are grounded in the expertise of an elite team of industry veterans. We are determined to innovate: to question accepted wisdom, create new ideas, offer new approaches and never rest on our laurels. We are self-starters who reimagine creative solutions for patients’ and doctors’ needs. We work passionately to retain the entrepreneurial spirit that created Glenmark more than 40 years ago.